Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIEOP-BFM 2017 Poland for pediatric acute lymphoblastic leukemia
2020-005017-41Phase 3Active
- Sponsor
- Medical University of Silesia
- Start
- Nov 2020
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bortezomib in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Medical University of Silesia. Started Nov 2020; status: active.
02
Drugs
bortezomib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2020-005017-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005017-41.